BR9812148A - Derivados de eritromicina 6,9-ligados em ponte - Google Patents
Derivados de eritromicina 6,9-ligados em ponteInfo
- Publication number
- BR9812148A BR9812148A BR9812148-0A BR9812148A BR9812148A BR 9812148 A BR9812148 A BR 9812148A BR 9812148 A BR9812148 A BR 9812148A BR 9812148 A BR9812148 A BR 9812148A
- Authority
- BR
- Brazil
- Prior art keywords
- erythromycin derivatives
- compound
- effective amount
- pharmaceutically acceptable
- bridged erythromycin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
"DERIVADOS DE ERITROMICINA 6,9-LIGADOS EM PONTE" São revelados novos compostos eritromicina multicíclicos e sais farmaceuticamente aceitáveis e ésteres dos mesmos possuindo atividade antibacteriana possuindo a fórmula (I), (II) ou (III), composições compreendendo uma quantidade terapeuticamente eficaz de um composto da invenção, em combinação com um veículo farmaceuticamente aceitável, bem como um processo para tratamento de infecções bacterianas por administração a um mamífero, de uma composição farmacêutica contendo uma quantidade farmaceuticamente eficaz de um composto da invenção.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/925,582 US5780605A (en) | 1997-09-08 | 1997-09-08 | 6,9-bridged erythromycin derivatives |
PCT/US1998/018225 WO1999012947A1 (en) | 1997-09-08 | 1998-09-01 | 6,9-bridged erythromycin derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9812148A true BR9812148A (pt) | 2000-07-18 |
Family
ID=25451953
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9812148-0A BR9812148A (pt) | 1997-09-08 | 1998-09-01 | Derivados de eritromicina 6,9-ligados em ponte |
Country Status (24)
Country | Link |
---|---|
US (1) | US5780605A (pt) |
EP (1) | EP1015467B1 (pt) |
JP (1) | JP2001515915A (pt) |
KR (1) | KR20010023756A (pt) |
CN (1) | CN1269803A (pt) |
AR (1) | AR015434A1 (pt) |
AT (1) | ATE257484T1 (pt) |
AU (1) | AU9216298A (pt) |
BG (1) | BG104288A (pt) |
BR (1) | BR9812148A (pt) |
CA (1) | CA2301643A1 (pt) |
CO (1) | CO4970722A1 (pt) |
DE (1) | DE69821009T2 (pt) |
DK (1) | DK1015467T3 (pt) |
ES (1) | ES2213915T3 (pt) |
HU (1) | HUP0003571A2 (pt) |
IL (1) | IL134220A0 (pt) |
NO (1) | NO20001169L (pt) |
PL (1) | PL339137A1 (pt) |
PT (1) | PT1015467E (pt) |
SK (1) | SK3032000A3 (pt) |
TR (1) | TR200000620T2 (pt) |
WO (1) | WO1999012947A1 (pt) |
ZA (1) | ZA987688B (pt) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7910558B2 (en) * | 2002-05-13 | 2011-03-22 | Enanta Pharmaceuticals, Inc. | Bridged macrocyclic compounds and processes for the preparation thereof |
US7273853B2 (en) * | 2002-05-13 | 2007-09-25 | Enanta Pharmaceuticals, Inc. | 6-11 bicyclic ketolide derivatives |
US6841664B2 (en) * | 2002-07-25 | 2005-01-11 | Enanra Pharmaceuticals, Inc. | 6,11-4-carbon bridged ketolides |
US7464097B2 (en) * | 2002-08-16 | 2008-12-09 | Sap Ag | Managing data integrity using a filter condition |
US7091196B2 (en) * | 2002-09-26 | 2006-08-15 | Rib-X Pharmaceuticals, Inc. | Bifunctional heterocyclic compounds and methods of making and using same |
KR20060002800A (ko) * | 2003-03-05 | 2006-01-09 | 립-엑스 파마슈티칼즈, 인크. | 이관능성 헤테로시클릭 화합물, 및 그의 제조 및 사용 방법 |
EP1682563A1 (en) * | 2003-10-30 | 2006-07-26 | Rib-X Pharmaceuticals, Inc. | Bifunctional macrolide heterocyclic compounds and mehtods of making and using the same |
US20070270357A1 (en) * | 2003-11-18 | 2007-11-22 | Farmer Jay J | Bifunctional Macrolide Heterocyclic Compounds and Methods of Making and Using the Same |
US7414030B2 (en) * | 2004-01-07 | 2008-08-19 | Enanta Pharmaceuticals, Inc. | 6-11 Bicyclic erythromycin derivatives |
WO2005070113A2 (en) * | 2004-01-09 | 2005-08-04 | Enanta Pharmaceuticals, Inc. | 9n-substituted 6-11 bicyclic erythromycin derivatives |
WO2005080408A1 (en) * | 2004-01-23 | 2005-09-01 | Enanta Pharmaceuticals, Inc. | Bridged macrocyclic compounds and processes for the preparation thereof |
US7384921B2 (en) * | 2004-02-20 | 2008-06-10 | Enanta Pharmaceuticals, Inc. | Polymorphic forms of 6-11 bicyclic ketolide derivatives |
EP2716647A3 (en) | 2004-02-27 | 2014-08-20 | Rib-X Pharmaceuticals, Inc. | Macrocyclic compounds and methods of making and using the same |
US20060252710A1 (en) * | 2005-05-04 | 2006-11-09 | Guoqiang Wang | 6-11 Bridged oxime erythromycin derivatives |
MX2007013730A (es) * | 2005-05-04 | 2008-01-28 | Enanta Pharm Inc | Derivados de eritromicina oxima con puente 6-11. |
US7384922B2 (en) * | 2005-05-04 | 2008-06-10 | Enanta Pharmaceuticals, Inc. | 6-11 bridged oxime erythromycin derivatives |
US8354383B2 (en) * | 2007-09-17 | 2013-01-15 | Enanta Pharmaceuticals, Inc. | 6,11-bridged biaryl macrolides |
US8273720B2 (en) * | 2007-09-17 | 2012-09-25 | Enanta Pharmaceuticals, Inc. | 6,11-bicyclolides: bridged biaryl macrolide derivatives |
JP5642548B2 (ja) * | 2007-09-17 | 2014-12-17 | エナンタ ファーマシューティカルズ インコーポレイテッド | 6,11−架橋ビアリールマクロライド |
TW200946109A (en) * | 2008-05-09 | 2009-11-16 | Enanta Pharm Inc | Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6248696A (ja) * | 1985-08-27 | 1987-03-03 | Kanegafuchi Chem Ind Co Ltd | N−〔1(s)−エトキシカルボニル−3−フエニルプロピル〕−l−アラニル−l−プロリンの製造法 |
KR960000434B1 (ko) * | 1986-12-17 | 1996-01-06 | 다이쇼 세이야꾸 가부시끼가이샤 | 에리스로마이신 a유도체 및 그의 제조 방법 |
MX9300278A (es) * | 1992-01-21 | 1993-12-31 | Abbott Lab | Compuestos de arilalcoxifenoxi-imidazolina. |
DK0638584T3 (da) * | 1992-04-22 | 1996-04-15 | Taisho Pharmaceutical Co Ltd | 5-O-desosaminyl-erythronolid-A-derivat |
MY113693A (en) * | 1992-05-26 | 2002-05-31 | Chugai Pharmaceutical Co Ltd | Erythromycin derivatives having an enterokinesis stimulating action |
HRP930014A2 (en) * | 1993-01-08 | 1994-08-31 | Pliva Pharm & Chem Works | 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates |
FR2719587B1 (fr) * | 1994-05-03 | 1996-07-12 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
US5712253A (en) * | 1996-06-18 | 1998-01-27 | Abbott Laboratories | Macrocyclic 13-membered ring derivatives of erythromycins A and B |
-
1997
- 1997-09-08 US US08/925,582 patent/US5780605A/en not_active Expired - Lifetime
-
1998
- 1998-08-25 ZA ZA987688A patent/ZA987688B/xx unknown
- 1998-09-01 CA CA002301643A patent/CA2301643A1/en not_active Abandoned
- 1998-09-01 EP EP98944680A patent/EP1015467B1/en not_active Expired - Lifetime
- 1998-09-01 HU HU0003571A patent/HUP0003571A2/hu unknown
- 1998-09-01 DE DE1998621009 patent/DE69821009T2/de not_active Expired - Fee Related
- 1998-09-01 AU AU92162/98A patent/AU9216298A/en not_active Abandoned
- 1998-09-01 WO PCT/US1998/018225 patent/WO1999012947A1/en active IP Right Grant
- 1998-09-01 CN CN98808883A patent/CN1269803A/zh active Pending
- 1998-09-01 JP JP2000510753A patent/JP2001515915A/ja not_active Withdrawn
- 1998-09-01 BR BR9812148-0A patent/BR9812148A/pt not_active IP Right Cessation
- 1998-09-01 IL IL13422098A patent/IL134220A0/xx unknown
- 1998-09-01 DK DK98944680T patent/DK1015467T3/da active
- 1998-09-01 TR TR2000/00620T patent/TR200000620T2/xx unknown
- 1998-09-01 PT PT98944680T patent/PT1015467E/pt unknown
- 1998-09-01 KR KR1020007002412A patent/KR20010023756A/ko not_active Application Discontinuation
- 1998-09-01 AT AT98944680T patent/ATE257484T1/de not_active IP Right Cessation
- 1998-09-01 PL PL98339137A patent/PL339137A1/xx unknown
- 1998-09-01 SK SK303-2000A patent/SK3032000A3/sk unknown
- 1998-09-01 ES ES98944680T patent/ES2213915T3/es not_active Expired - Lifetime
- 1998-09-04 CO CO98050780A patent/CO4970722A1/es unknown
- 1998-09-07 AR ARP980104455A patent/AR015434A1/es unknown
-
2000
- 2000-03-07 NO NO20001169A patent/NO20001169L/no not_active Application Discontinuation
- 2000-03-30 BG BG104288A patent/BG104288A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
EP1015467B1 (en) | 2004-01-07 |
IL134220A0 (en) | 2001-04-30 |
ZA987688B (en) | 1999-02-24 |
JP2001515915A (ja) | 2001-09-25 |
DK1015467T3 (da) | 2004-05-03 |
DE69821009D1 (de) | 2004-02-12 |
EP1015467A1 (en) | 2000-07-05 |
CO4970722A1 (es) | 2000-11-07 |
CN1269803A (zh) | 2000-10-11 |
HUP0003571A2 (hu) | 2001-02-28 |
NO20001169D0 (no) | 2000-03-07 |
SK3032000A3 (en) | 2000-07-11 |
BG104288A (bg) | 2001-01-31 |
PT1015467E (pt) | 2004-05-31 |
AU9216298A (en) | 1999-03-29 |
AR015434A1 (es) | 2001-05-02 |
NO20001169L (no) | 2000-04-05 |
KR20010023756A (ko) | 2001-03-26 |
TR200000620T2 (tr) | 2000-09-21 |
US5780605A (en) | 1998-07-14 |
ATE257484T1 (de) | 2004-01-15 |
ES2213915T3 (es) | 2004-09-01 |
WO1999012947A1 (en) | 1999-03-18 |
PL339137A1 (en) | 2000-12-04 |
CA2301643A1 (en) | 1999-03-18 |
DE69821009T2 (de) | 2004-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9812148A (pt) | Derivados de eritromicina 6,9-ligados em ponte | |
BRPI9810519A (pt) | derivados de 4''-substituído-9-desoxo-9a-aza-9a-homoeritromicina a e composição farmacêutica compreendendo os mesmos. | |
BR9812577A (pt) | Composto, processo para preparar o mesmo, composição farmacêutica, e, processo para tratar infecções bacterianas | |
BR9802851A (pt) | Antibióticos de macrolìdeo substituìdos por c-4 | |
BR9813319A (pt) | Composto, composição farmacêutica para tratamento de infecções bacterianas, e, processos para tratar infecções bacterianas e para preparar um composto | |
BR9714269A (pt) | Composto, composição farmacêutica, e, processos para controlar uma infecção bacteriana em um mamìfero e para a preparação de compostos macrólidos tricìclicos | |
BR9810097A (pt) | Derivados de macrolìdeos c-4-substituìdos | |
BR9714287A (pt) | Antibiótico cristalino designado solvato 6-o-metileritromicina forma 0, solvato de 6-o-metileritromicina forma 0, composição, processos para tratamento de infecções bacterianas em um mamìfero hospedeiro com necessidade de tal tratamento e para preparação de solvato de 6-o-metileritomicina a forma 0, 6-o-metileritromicina forma 0--etanolato, suspensão para administração oral, e, complexo de solvato de 6-o-metileritromicina a forma 0-carbÈmero. | |
BR0001468A (pt) | ácidos dioxiciclopentil hidroxânicos | |
TR199901127T2 (xx) | Antibakteriyel etkili 6-O-ikameli ketolitler. | |
BR0000003A (pt) | Azalidas e métodos de preparação das mesmas | |
BR9814601A (pt) | "macrólidos" | |
BR9813317A (pt) | Composto, composição farmacêutica para tratar infecções bacterianas, e, processos para tratar infecções bacterianas, e para preparar um composto | |
BR9806870A (pt) | Composto, processo para a profilaxia ou tratamento de uma condição clìnica em um mamìfero, formulação farmacêutica, e, uso de um composto e processo para preparar o mesmo. | |
BR9502016A (pt) | Derivado de propiofenona processo para a preparação do mesmo composição farmacêutica agente antidiabete e uso do dito derivado | |
RU94022743A (ru) | Амидо- или карбамидо-производные, обладающие антигиперхолестериновой активностью, и фармацевтическая композиция на их основе | |
BRPI9915480B8 (pt) | azalídeos de 13 membros, composições farmacêuticas compreendendo os mesmos, método para sua preparação bem como seus usos. | |
EA200100623A1 (ru) | Кетолидные антибиотики | |
EA200100396A1 (ru) | Новые макролидные антибиотики | |
BR9905089A (pt) | Derivados macrolìdeos | |
AR007021A1 (es) | Derivados de 3-descladinosa-2,3-anhidroeritromicina, procedimientos para su preparacion, compuestos para su exclusivo uso en dichos procedimientosy procedimiento para su preparacion, una composicion farmaceutica para tratar infecciones bacterianas y el uso de estos compuestos para preparar medicamentos | |
BR0006301A (pt) | Macrólidos antibacterianos e pró-cinéticos | |
BR0006299A (pt) | Derivados da 4-oxo-2-ureìdo-1,4,5,6-tetra-hidro-pirimidina | |
BR9708929A (pt) | Composto composição farmacêutica e processos para controlar uma infecção bacteriana em um mamífero e para preparar compostos de macrólidos | |
WO1999011651A3 (en) | 3-descladinose 6-o-substituded erythromycin derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5O, 6O, 7O, 8O E 9O ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007. |